Government officials are suggesting to use Biological E’s Corbevax COVID-19 vaccine for children of age 5-11 years.
Government officials on Thursday an expert committee of the Central Drug Authority of India suggests that Biological E’s COVID19 vaccine Corbevax be allotted as an emergency permit to children of age 5 to 11 years, subject to certain terms and conditions.
“The Subject Expert Committee (SEC) on COVID-19 of the CDSCO which deliberated on the application recommended granting restricted emergency use authorisation to Biological E’s Corbevax for the 12 to less than 18 years age group subject to certain conditions,” sources said.
On February 9, Srinivas Kosaraju, Head of Quality and Regulatory Issues at Biological E Limited, submitted to DCGI that the company will conduct a Phase 2/3 clinical trial of Corbevax in 5 to 18 year-old children and adolescents. Said it was approved in September.
Johns Hopkins scientist Amita Gupta said on Thursday that immunization fairness has increased in both India, where less than 2% of the population has received a Covid booster, and India, where 56 countries around the world cannot be vaccinated with even 10% of the population. I said there is. One problem remains.
Johns Hopkins University School of Medicine Dean and Professor of Infectious Diseases emphasizes that no one in the world is safe from Covid until everyone in the world is vaccinated, while hospitalization tracking is a descriptive indicator. Said. The severity of the illness is key.
The government officials is taking every possible step to avoid any kind of chaos again be it the Central government or state government everyone is trying their best to do what is in the favour of the nation.
About Corbevax:-
Biological E Limited’s Corbevax vaccine is India’s first unique receptor-binding domain (RBD) protein subunit vaccine against COVID19. DCGI had already approved Corbevax on December 28 for limited use in adult emergencies. The Corbevax vaccine is given intramuscularly at two planned doses at 28-day intervals and is stored at 2-8 degrees Celsius in 0.5 ml (single dose) and 5 ml (10 doses) vial packs.
The Corbevax vaccine given to children aged 12-14 years now costs 990 rupees in the private market and 145 rupees in public hospitals and institutions, including all taxes.
However, Covid19’s expert committee has requested further data from Bharat Biotech to consider an Emergency Use Authorization (EUA) application for the use of covaxin in individuals aged 2 to 11 years.
also read: India exceedes COVID deaths statement inaccurate , says WHO technical group member
